Dr. Rosenfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3833 Greenbrier
Dallas, TX 75225Phone+1 214-810-8489- Is this information wrong?
Education & Training
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1979 - 1982
- University of Missouri Kansas City School of MedicineClass of 1979
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology
Certifications & Licensure
- TX State Medical License 1994 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine
Clinical Trials
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission Start of enrollment: 2005 May 01
- Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Search for Sterile Neutrinos in MINOS and MINOS+ Using a Two-Detector Fit.Adamson, P.,Anghel, I.,Aurisano, A.,Barr, G.,Bishai, M.,Blake, A.,Bock, G. J.,Bogert, D.,Cao, S. V.,Carroll, T. J.,Castromonte, C. M.,Chen, R.,Childress, S.,Coelho, JA...> ;Phys. Rev. Lett.. 2019 Apr 02
- Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.Kantarjian, H., Issa, J.J., Rosenfeld, C.S., Bennett, J.M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., Helmer, R., Shen, L., Nimer, ...> ;Cancer. 2006 Apr 15
- 8 citationsClinical Development of Decitabine as a Prototype for an Epigenetic Drug ProgramCraig S. Rosenfeld> ;Seminars in Oncology. 2005 Oct 1
- Join now to see all
Press Mentions
- Collaborative Medicinal Development, LLC Reports That Lead Drug Shows Dose-Dependent Improvement in Parkinson's DiseaseJune 10th, 2019
- Collaborative Medicinal Development LLC Wins AU$1 Million Grant Award from FightMNDApril 18th, 2019
- Collaborative Medicinal Development, LLC Reports That Lead Drug Modifies ALS ProgressionJanuary 7th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: